Sektor Caplin Point Laboratories Limited NSE India S.E.
Aktien
A2DSTM
INE475E01026
CAPLIPOINT
Pharmazeutika
|
Verzögert
NSE India S.E.
12:01:44 02.09.2026
|
% 5 Tage | Veränd. 1. Jan. | ||
| 2’720.50 INR | +0.34% |
|
+8.12% | +48.01% |
| 14.08. | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| 12.08. | Caplin Point Laboratories Limited legt Ergebnisse für das erste Quartal zum 30. Juni 2026 vor | CI |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.14% | +1.70% | -1.62% | +7.92% | +12.33% | +23.42% | +74.20% | +144.53% | +146.91% | 48.77 Mrd. | |
| -1.61% | -0.29% | +6.00% | +7.73% | +37.38% | +51.58% | +118.38% | +156.04% | +169.75% | 40.67 Mrd. | |
| -1.16% | +0.37% | +2.96% | +7.04% | +26.23% | +15.87% | +86.01% | +107.40% | +200.14% | 12.27 Mrd. | |
| -0.72% | +0.72% | -4.18% | +2.43% | -6.52% | -9.97% | +14.04% | +47.90% | +144.45% | 12.11 Mrd. | |
| +0.57% | +1.73% | +1.93% | +3.73% | +30.30% | +31.59% | +153.11% | +139.37% | +346.19% | 9.28 Mrd. | |
| -1.75% | -3.16% | +7.96% | +2.55% | +30.56% | +23.97% | +44.23% | +47.71% | +125.17% | 7.55 Mrd. | |
| -0.42% | +0.89% | +10.31% | +12.61% | +20.87% | +28.21% | +223.05% | +356.91% | +193.35% | 7.35 Mrd. | |
| -0.62% | -0.84% | +5.67% | +11.44% | +13.69% | +44.70% | -11.26% | -7.92% | -7.59% | 7.3 Mrd. | |
| -0.13% | -0.16% | -4.24% | -2.84% | -35.68% | -40.47% | +15.85% | +25.03% | +10.85% | 5.25 Mrd. | |
| -0.66% | -1.97% | -0.92% | +19.56% | +25.74% | +40.39% | +102.48% | +136.00% | +171.08% | 4.61 Mrd. | |
| -1.14% | +5.25% | +4.96% | +8.66% | +34.00% | +49.66% | -7.31% | -17.85% | -54.83% | 4.31 Mrd. | |
| +2.60% | +1.20% | +0.68% | +6.03% | -15.13% | -23.37% | +55.75% | +87.53% | +13.73% | 2.77 Mrd. | |
| +2.90% | +1.18% | -6.12% | -3.15% | +31.68% | +34.57% | +690.00% | +353.30% | +133.10% | 3.17 Mrd. | |
| -0.51% | -2.09% | +8.99% | +1.27% | -4.16% | -4.16% | +47.29% | +203.80% | +746.11% | 2.91 Mrd. | |
| -1.55% | -2.54% | +10.49% | -49.37% | -28.90% | -10.26% | +86.57% | +198.38% | +1’724.50% | 2.82 Mrd. | |
| -2.81% | -5.15% | -12.78% | -10.47% | -9.50% | -0.98% | +43.62% | +10.34% | +57.49% | 2.54 Mrd. | |
| -0.73% | -4.18% | -1.39% | -12.73% | -5.06% | -13.84% | +18.72% | - | - | 2.54 Mrd. | |
| -0.11% | +3.03% | +2.18% | -14.93% | +7.51% | -51.01% | +77.42% | +58.53% | - | 2.41 Mrd. | |
| +0.14% | +7.77% | +5.89% | +36.65% | +47.44% | +27.49% | +153.64% | +267.70% | +1’008.63% | 2.17 Mrd. | |
| Durchschnitt | -0.40% | +0.11% | +1.94% | +1.80% | +11.20% | +11.44% | +104.52% | +128.59% | +301.71% | 9.52 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | -0.58% | +0.89% | +2.00% | +5.61% | +18.01% | +24.40% | +93.45% | +131.57% | +194.69% |
- Börse
- Aktien
- A2DSTM Aktie
- A2DSTM Aktie
- Sektor Caplin Point Laboratories Limited
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
